Is Wegovy on the PBS? Weight Loss Medication & the PBS in Australia (2026)

The single most common question Australian patients ask about weight loss medication is some version of: "is it on the PBS?" It's the right question — PBS listing is the difference between paying around $31.60 per script and paying $200–$460 a month privately.

Here is the complete, accurate PBS picture for weight loss medications in Australia as at mid-2026.

PBS status of every major weight loss medication

The pattern is stark: no medication is currently PBS-subsidised when prescribed for weight management. Ozempic's PBS listing applies only to type 2 diabetes, which is why a diabetes patient pays a PBS co-payment while a weight management patient pays the full private price for the same pen.

Is Wegovy on the PBS in Australia?

No. As at mid-2026, Wegovy is not listed on the PBS. Novo Nordisk has pursued PBS listing for semaglutide in weight management, and the Pharmaceutical Benefits Advisory Committee (PBAC) has considered obesity medications multiple times — but cost-effectiveness at population scale remains the sticking point. Until a listing happens, Wegovy is a private script. Current pricing is covered in our Wegovy cost guide. Full detail: our dedicated Wegovy PBS guide.

Is Mounjaro on the PBS?

No — same situation. Mounjaro (tirzepatide) is TGA-registered for weight management but not PBS-listed for it, so patients pay $230–$460 a month depending on dose. Our dose-by-dose Mounjaro price guide shows where the money goes. Full detail: our dedicated Mounjaro PBS guide.

Will weight loss medication ever be PBS-listed?

Momentum is real. Obesity is formally recognised as a chronic disease by Australian clinical bodies, PBAC has been actively engaging with manufacturers, and the economic case strengthens every year as evidence accumulates that GLP-1 medications reduce downstream costs — heart disease, type 2 diabetes, joint replacements. Most observers expect some form of restricted PBS listing eventually (likely targeted at higher-BMI patients with comorbidities first), but no listing has been confirmed as at mid-2026. When the situation changes, we will update this page.

What IS subsidised: the medical care around the medication

Here's the part most patients miss. While the medication itself is private, the GP care around it can cost you nothing:

• GP consultations — assessment, prescribing and dose-review consultations can be bulk billed through Medicare. Ours are, for eligible Medicare card holders.
• Pathology — baseline and monitoring blood tests are typically bulk billed when medically indicated.
• Chronic disease management plans — if you have a weight-related chronic condition, a GP Management Plan can unlock Medicare-subsidised dietitian and exercise physiologist sessions.

Over a year of treatment, bulk billed care easily saves $500–$1,000 compared to paying private consultation fees on top of medication costs. That's the model this clinic is built on — the consultation is bulk billed, and your only cost is the pharmacy price of the medicine. More detail in our guide to bulk billed weight loss treatment.

How do I start?

Request an appointment — it takes two minutes, there's no referral needed, and the consultation is bulk billed for eligible Medicare card holders. Your GP will talk through which medication (if any) suits your situation and what it will actually cost you at the pharmacy.

PBS information current as at mid-2026. PBS listings change — check pbs.gov.au for the latest schedule, and confirm prices with your pharmacy.